87C-24333-73028
2 vaccinations
6 coded responses
22 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 024 / MA
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Registered in v-safe
-
2021-03-27
Dose 1 — Pfizer-BioNTech
- 2021-03-27
-
2021-03-28
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: I have dysautonomia and mast cell activation so any trigger could have caused the symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction, Pre-existing disease — Feeling: Poor · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: I received immunoglobulin therapy today and my symptoms are likely from thatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Good · Muscle or body aches, Fatigue or tirednessFree text: Dysautonomia & (b)(6)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
-
2021-04-03
Survey response — day 7, dose 1MedDRA: Autoimmune disorder, Autonomic nervous system imbalance, Limb discomfort — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: I have dysautonomia and autoimmune autonomic ganglionopathy & am recovering from spinal surgeryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-10
-
2021-04-17
Dose 2 — Pfizer-BioNTech
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-24
-
2021-05-01
Survey response — day 14, dose 2MedDRA: Fatigue, Migraine, Myalgia, Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: For two days I had an incredible migraine that would not abate, full-body muscle aches, intense nausea and significant fatigue. Then it randomly got better.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
-
2021-07-17
Survey response — 3 months, dose 2MedDRA: Pruritus, Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Significant itching and rashesMedDRA releases: 2024-11 · check-in free text available
-
2021-07-17
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-24
- 2021-07-26
-
2021-07-26
Call successfulDoes not wish to fill out VAERS report
- 2021-10-16
- 2022-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-17 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): I have dysautonomia and mast cell activation so any trigger could have caused the symptoms
Systemic reaction (other): I received immunoglobulin therapy today and my symptoms are likely from that
Release 6 — day 7, dose 1
Systemic reaction (other): I have dysautonomia and autoimmune autonomic ganglionopathy & am recovering from spinal surgery
Release 8 — day 14, dose 2
Symptoms: For two days I had an incredible migraine that would not abate, full-body muscle aches, intense nausea and significant fatigue. Then it randomly got better.
Release 9 — 3 months, dose 2
Symptoms: Significant itching and rashes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Autoimmune disorder | ✓ | ✓ | ✓ |
| SRO | Autonomic nervous system imbalance | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Limb discomfort | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release